Massive arthritis registry aims to unlock secrets of best treatments
NCT ID NCT02530268
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is a large registry that will follow 5,000 people with psoriatic arthritis or spondyloarthritis across North America. Researchers will collect information on how different approved treatments work and their side effects over time. The goal is to better understand these diseases, their natural course, and what treatments are most effective in real-world practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANKYLOSING SPONDYLITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A single blood test may reveal whether a gene tied to transplant outcomes influences psoriatic arthritis risk.
- New antibody aims to calm ankylosing spondylitis
- Can a 4-Minute chat rival a Dietitian's hour for heart health?
- Ultrasound and EMG may tell inflammatory from mechanical shoulder issues
- Your plate may fight psoriatic arthritis: diet study tests food as medicine
- Real-World study tests whether aggressive early treatment improves psoriatic arthritis outcomes